Supplementary Table S1 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors

類似資料

• Supplementary Table S2 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
  著者:: Clare F. Malone (14960925)
  出版事項: (2025)
• Supplementary Table S3 from Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
  著者:: Clare F. Malone (14960925)
  出版事項: (2025)
• Supplementary Data File S8 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
  著者:: Katie E. Hebron (15046889)
  出版事項: (2025)
• Supplemental Data File S3 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
  著者:: Katie E. Hebron (15046889)
  出版事項: (2025)
• Supplementary Data File S1 from The Combination of Trametinib and Ganitumab is Effective in RAS-Mutated PAX-Fusion Negative Rhabdomyosarcoma Models
  著者:: Katie E. Hebron (15046889)
  出版事項: (2025)